EN

Spatial Chromatin-Immune Profiling and Immunotherapy-Response Stratification of Glioblastoma Niches in a North African Cohort

Morocco | Biomedical and Clinical Sciences

Swiss partners

  • USI : Haitham Shaban

 MENA partners

  • Université Hassan II de Casablanca : Abdallah Badou

Presentation of the project

Glioblastoma is one of the most aggressive and difficult-to-treat brain cancers. Even after surgery, radiotherapy and chemotherapy, the tumour often returns, leaving patients and doctors with very limited options. A major challenge is that glioblastoma can protect itself by creating “safe zones” inside the tumour, where immune cells are blocked, weakened, or kept too far from cancer cells to attack.

This Swiss–Moroccan pilot project aims to uncover these hidden protective zones in glioblastoma tissue from North African patients, a population still under-represented in cancer research. Using advanced spatial mapping technologies, we will create detailed maps of the tumour microenvironment, showing where cancer cells, immune cells and tumour-supporting cells are located, how they interact, and how the tumour may escape immune attack.

We will combine these maps with AI-based image and data analysis to detect patterns that are difficult to see by eye. A key focus will be chromatin organization — the way DNA is packaged inside the cell nucleus — because it can reveal changes linked to tumour aggressiveness, immune evasion and treatment response.

One primary objective is to stratify glioblastoma patients based on their immune profiles, immune checkpoint expression and spatial chromatin organization. This may help predict which patients are more or less likely to benefit from immunotherapy.

In the long term, the project will lay the foundation for larger studies across North Africa and the wider MENA region, helping to make brain cancer research more inclusive, globally relevant and closer to patients’ needs.